Texas 2017 85th Regular

Texas Senate Bill SB1601 Introduced / Bill

Filed 03/09/2017

                    85R9229 KKR-F
 By: Miles S.B. No. 1601


 A BILL TO BE ENTITLED
 AN ACT
 relating to the establishment by certain counties and
 municipalities of disease control programs to reduce the risk of
 certain infectious and communicable diseases; authorizing fees.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 531.0972, Government Code, is amended to
 read as follows:
 Sec. 531.0972.  [PILOT] PROGRAM TO PREVENT [THE] SPREAD OF
 CERTAIN INFECTIOUS OR COMMUNICABLE DISEASES. The Department of
 State Health Services [commission] may provide guidance to the
 counties and municipalities that establish [local health authority
 of Bexar County in establishing] a [pilot] program under Subchapter
 K, Chapter 81, Health and Safety Code, [funded by the county] to
 prevent the spread of HIV, hepatitis B, hepatitis C, and other
 infectious and communicable diseases.  The program may include a
 disease control program that provides for the anonymous exchange of
 used hypodermic needles and syringes.
 SECTION 2.  Chapter 81, Health and Safety Code, is amended by
 adding Subchapter K to read as follows:
 SUBCHAPTER K. PROGRAM TO REDUCE RISK OF CERTAIN COMMUNICABLE
 DISEASES
 Sec. 81.501.  DEFINITIONS. In this subchapter:
 (1)  "Organization" means an entity authorized by a
 county or municipality to operate a program under this subchapter.
 (2)  "Program" means a program established under this
 subchapter to control through needle exchange the spread of HIV,
 hepatitis B, hepatitis C, or other infectious and communicable
 diseases.
 Sec. 81.502.  AUTHORITY TO ESTABLISH PROGRAM. (a) An
 organization may operate a program in a county or municipality in
 which a public health emergency described by Subsection (b) is
 declared by the commissioner.
 (b)  The commissioner may declare a public health emergency
 in a county or municipality if a county or municipality
 demonstrates that:
 (1)  an epidemic of HIV, hepatitis B, hepatitis C, or
 other infectious and communicable diseases exists in the county or
 municipality;
 (2)  the primary cause of the transmission of HIV,
 hepatitis B, hepatitis C, or other infectious and communicable
 diseases is intravenous drug use;
 (3)  other measures used to control the epidemic are
 unsuccessful; and
 (4)  a needle exchange program is a medically
 appropriate component of a comprehensive response to the epidemic.
 (c)  To request the department declare a public health
 emergency, the commissioners court of a county or the governing
 body of a municipality shall:
 (1)  conduct a public hearing and allow public
 testimony on HIV, hepatitis B, hepatitis C, or other infectious and
 communicable diseases in the county or municipality;
 (2)  issue an order requesting the department to
 declare a public health emergency in the county or municipality
 with facts supporting the declaration; and
 (3)  submit to the department an official request and
 supporting evidence for the department to declare a public health
 emergency in the county or municipality.
 (d)  On receipt of a request by a county or municipality to
 declare a public health emergency under this subchapter, the
 commissioner shall:
 (1)  approve, deny, or request additional information
 from the county or municipality concerning the request not later
 than the 10th day after the date the request is received by the
 department; or
 (2)  if additional information is requested by the
 department, approve or deny a request not later than the 10th day
 after the additional information is received.
 (e)  A public health emergency declared under this section
 remains in effect until the first anniversary of the date the
 emergency is declared.
 (f)  The commissioner may extend a declaration of a public
 health emergency at the request of the county or municipality that
 is the subject of the declaration.
 Sec. 81.503.  REGISTRATION REQUIRED.  An organization shall
 register with the department and the county or municipality in
 which the organization is applying to operate a program to
 distribute hypodermic needles and syringes for the purpose of
 controlling the spread of HIV, hepatitis B, hepatitis C, or other
 infectious and communicable diseases.  The department, county, or
 municipality may charge a reasonable fee for registration under
 this subchapter to pay for oversight functions, including
 coordination with law enforcement personnel.
 Sec. 81.504.  PROGRAM OPERATION. A qualified organization
 that is registered to provide a program in a county or municipality
 shall:
 (1)  operate the program in a manner consistent with
 public health and safety and under the supervision of a physician,
 physician assistant, or nurse licensed to practice in this state;
 (2)  ensure the program is medically appropriate and
 part of a comprehensive public health response;
 (3)  provide for the anonymous exchange of used
 hypodermic needles and syringes for an equal number of new
 hypodermic needles and syringes; and
 (4)  provide:
 (A)  education and training on responding to and
 treating a drug overdose, including the administration of an
 overdose intervention drug;
 (B)  information on options for drug
 rehabilitation treatment; and
 (C)  assistance to program participants with
 obtaining drug rehabilitation treatment, including treatment
 programs located in the county or municipality in which the program
 operates and treatment programs that offer medication-assisted
 treatment using a medication that is:
 (i)  approved by the United States Food and
 Drug Administration for use in opioid or alcohol dependence
 treatment; and
 (ii)  long-acting and nonaddictive.
 Sec. 81.505.  DISTRIBUTION OF NEEDLES AND SYRINGES TO
 PROGRAM. A person licensed as a wholesale drug distributor or
 device distributor under Chapter 431 may distribute hypodermic
 needles and syringes to a program authorized by this subchapter.
 Sec. 81.506.  HANDLING OF NEEDLES AND SYRINGES. (a)  An
 organization operating a program authorized by this subchapter
 shall store hypodermic needles and syringes in a proper and secure
 manner. Only authorized employees or volunteers of the program may
 have access to the hypodermic needles and syringes. The hypodermic
 needles and syringes may be included in packaged safe kits made
 available to program clients through the program. Program clients
 may obtain hypodermic needles and syringes and safe kits only from
 an authorized employee or volunteer of the program.
 (b)  An organization operating a program authorized by this
 subchapter shall store and dispose of used hypodermic needles and
 syringes in accordance with applicable state laws and
 administrative rules governing the safe and proper disposal of
 medical waste.
 Sec. 81.507.  REQUIRED REPORTING BY ORGANIZATION. (a) An
 organization operating a program under this subchapter shall submit
 to the department a quarterly report that provides:
 (1)  the number of individuals served by the
 organization each day;
 (2)  the number of hypodermic needles and syringes
 collected by the organization each day;
 (3)  the number of hypodermic needles and syringes
 distributed by the organization each day; and
 (4)  other information the department determines
 necessary.
 (b)  The information required under Subsection (a) must
 include the zip code of each location where the program distributed
 or collected hypodermic needles and syringes.
 Sec. 81.508.  REVOCATION. If an organization fails to
 comply with the requirements of this subchapter, the commissioners
 court of the county or the governing body of the municipality in
 which the organization is operating or the department may revoke
 the organization's registration and authorization to operate a
 program.
 Sec. 81.509.  USE OF STATE FUNDS. State funds may not be
 used to purchase hypodermic needles or syringes under this
 subchapter.
 Sec. 81.510.  DEPARTMENT REPORT.  The department shall
 annually submit to the legislature a report on:
 (1)  the effectiveness of the program;
 (2)  the program's impact on reducing the spread of HIV,
 hepatitis B, hepatitis C, and other infectious and communicable
 diseases; and
 (3)  the program's effect on intravenous drug use in the
 area served by the county or municipality.
 SECTION 3.  Section 481.125, Health and Safety Code, is
 amended by adding Subsections (g), (h), (i), and (j) to read as
 follows:
 (g)  Subsections (a) and (b) do not apply to a person who
 dispenses or delivers a hypodermic needle or syringe for a medical
 purpose.  For the purposes of this subsection, "medical purpose"
 includes the exchange of a hypodermic needle or syringe for a used
 hypodermic needle or syringe in a program described by Subchapter
 K, Chapter 81.
 (h)  Subsections (a) and (b) do not apply to a person who
 manufactures hypodermic needles or syringes for delivery to a
 program described by Subchapter K, Chapter 81.
 (i)  Subsections (a) and (b) do not apply to a person who is
 an employee, volunteer, duly authorized agent, or participant of a
 program described by Subchapter K, Chapter 81, and uses, possesses,
 or delivers a hypodermic needle or syringe as part of the program.
 (j)  A peace officer may not stop, search, or seize a person
 or base probable cause solely because the person visits an
 organization operating under Subchapter K, Chapter 81.
 SECTION 4.  The change to Section 481.125, Health and Safety
 Code, made by this Act applies only to an offense committed on or
 after the effective date of this Act. An offense committed before
 the effective date of this Act is governed by the law in effect when
 the offense was committed, and the former law is continued in effect
 for that purpose.  For purposes of this section, an offense is
 committed before the effective date of this Act if any element of
 the offense occurs before that date.
 SECTION 5.  This Act takes effect September 1, 2017.